DarioHealth Corp.
DRIO | NASDAQ
$7.07
-$0.13 (-1.81%)
At close: Sep 21, 2026, 4:00 PM ET
$6.95
-$0.12 (-1.70%)
After-hours:
Sep 21, 2026, 4:27 PM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 22.36M | 27.04M | 20.35M | 27.66M | 20.51M | 7.58M |
Cost of Revenue | 9.69M | 13.77M | 14.37M | 18M | 12.44M | 5.06M |
Gross Profit | 12.67M | 13.27M | 5.98M | 9.66M | 8.07M | 2.51M |
Operating Income | -36.66M | -57.74M | -56.19M | -56.81M | -76.49M | -29.9M |
Interest Income | 943K | 1.12M | 1.87M | 506K | 44K | 61K |
Pretax Income | -41.61M | -44.6M | -59.36M | -62.19M | -76.73M | -29.45M |
Net Income | -41.71M | -42.75M | -59.43M | -62.19M | -76.76M | -29.45M |
Selling & General & Admin | 35.53M | 46.83M | 41.8M | 46.82M | 62.36M | 27.98M |
Research & Development | 13.79M | 24.18M | 20.25M | 19.65M | 17.22M | 4.43M |
Other Expenses | n/a | n/a | 128K | n/a | 4.99M | n/a |
Operating Expenses | 49.32M | 71.01M | 62.17M | 66.47M | 84.56M | 32.42M |
Interest Expense | 3.36M | 96K | 645K | 2.68M | 84K | 49K |
Selling & Marketing Expenses | 20.34M | 26.35M | 23.79M | 30.32M | 39.71M | 15.23M |
Cost & Expenses | 59.01M | 84.78M | 76.41M | 84.47M | 97.01M | 37.48M |
Income Tax Expense | 105K | -1.85M | 64K | 4K | 32K | n/a |
Shares Outstanding (Basic) | 49.63M | 40.42M | 28.37M | 23.64M | 16.59M | 5.96M |
Shares Outstanding (Diluted) | 49.63M | 40.42M | 28.37M | 23.64M | 16.59M | 5.96M |
EPS (Basic) | -0.81 | -0.74 | -1.93 | -2.63 | -4.63 | -5.55 |
EPS (Diluted) | -0.81 | -0.74 | -1.93 | -2.63 | -4.63 | -5.55 |
EBITDA | -34.69M | -37.08M | -54.38M | -55.6M | -70.02M | -29.71M |
EBIT | -38.25M | -44.5M | -59.36M | -60.31M | -74.47M | -29.9M |
Depreciation & Amortization | 3.56M | 7.43M | 4.99M | 4.72M | 4.46M | 190K |
Add to Watchlist
Select watchlists to add or remove DRIO